The Patent Finder

Terms ending in 2036

Acceleron Pharma Inc.

Every in-force patent on Acceleron Pharma Inc.'s record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,975,934Follistatin-Related Fusion Proteins
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 11,001,614Method for Treating a Muscle-Related Disorder with Follistatin-Related Fusion Proteins
In force
 · Medium confidence
Acceleron Pharma Inc.In forceMedium confidence
US 10,227,393Tgf-Beta Superfamily Type I and Type II Receptor Heteromultimers and Uses Thereof
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 10,738,098ALK4:ACTRIIB Heteromultimers and Uses Thereof
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 10,906,958Tgf-Beta Superfamily Type I and Type II Receptor Heteromultimers and Uses Thereof
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 11,028,145ALK7:ACTRIIB Heteromultimers and Uses Thereof
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 11,279,746ALK4:ACTRIIB Heteromultimers and Uses Thereof
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 11,857,599Compositions and Methods for Treating Spinal Muscular Atrophy
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 12,024,563ALK7 Antagonists and Uses Thereof
In force
 · High confidence
Acceleron Pharma Inc.,In forceHigh confidence
US 10,196,434ALK4:ACTRIIB Heteromultimers and Uses Thereof
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
10 more term ends in 2036 · Pro
10 of 20 patents shown. Soonest term end first, then patent number.
Pro members see all 20.
Upgrade to Pro
17 of these are in force and held by Acceleron Pharma Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited